7,4- ( , Lee et al., 2016)
Research in humans is a bit less impressive Clinical trials in humans A 1981 double-blind study found that chronic insomniac patients found that subjects slept 59% more, shorter sleep latency, and higher sleep efficiency (Schneider 1981) A 1987 double-blind study did not find any statistically significant changes in sleep structure as measured by REM sleep, NREM sleep, or total sleep time (Debellis 1987) A 1992 double-blind study in 14 chronic insomnia patients found higher sleep efficiency and subjectively estimated tiredness decreased to similar levels of healthy subjects in 7 nights of injections (Schneider 1992) There are some limitations to these studies however
Considerations: Assess reasonable copper levels based on patient status
The human body does not produce it, so it has to be absorbed from foods and supplements
Reduced glutathione (GSH) and oxidized glutathione (GSSG) both exist in healthy cells, the majority of which is in reduced (GSH) form
If FDA later publishes a policy, the clinic should describe the scope, affected substances, pharmacy type, and conditions rather than using a blanket legality claim
